CSL760
CSL760_1001
Phase 1 mab terminated
Quick answer
CSL760 for Coronavirus Disease 2019 (COVID-19) is a Phase 1 program (mab) at CSL Behring GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CSL Behring GmbH
- Indication
- Coronavirus Disease 2019 (COVID-19)
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated